Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The CD4+ T-cell receptors (TCRs) specific for tetanus and diphtheria peptide-MHC class II complexes are essential mediators of the adaptive immune response to toxoid-based vaccines. These receptors, typically composed of alpha and beta polypeptide chains, are expressed on the surface of CD4+ helper T cells and possess unique complementarity-determining regions (CDRs) that allow for the precise recognition of tetanus and diphtheria-derived peptides (e.g., TT830-844) when bound to Major Histocompatibility Complex (MHC) class II molecules (Panina-Bordignon et al., 1989, Eur J Immunol; Rossjohn et al., 2015, Annu Rev Immunol). This interaction is the fundamental mechanism by which vaccines like Tdap and DTaP stimulate long-term immunological memory, as the resulting T-cell activation provides the necessary signals for B-cell maturation and high-affinity antibody production (CDC, 2021, Pink Book). In clinical research, these TCRs are used as model systems to study T-cell repertoire diversity, antigen-specific expansion, and the longevity of human immune memory (Kwok et al., 2000, J Immunol). Furthermore, the high prevalence of these TCRs in the general population makes their cognate peptides valuable helper epitopes in the design of conjugate vaccines and novel cancer immunotherapies (Slingluff, 2011, Cancer J). Monitoring the frequency and activation state of these TCR-bearing cells serves as a key biomarker for evaluating vaccine efficacy and the overall immune status of a patient.
The TCR complex recognizes specific antigenic peptides (e.g., TT830-844) presented by MHC class II molecules. This binding event, stabilized by the CD4 co-receptor, triggers the CD3 signaling cascade, leading to the activation of transcription factors like NFAT, NF-kappaB, and AP-1, which drive the expression of genes necessary for T-cell effector function and memory formation (Rossjohn et al., 2015, Annu Rev Immunol).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor specific for tetanus and diphtheria peptide-MHC class II complexes (Td-specific TCR) (Td-specific TCR).